Anti-Chlamydophila immunoglobulin prevalence in sarcoidosis and usual interstitial pneumoniae

European Respiratory Journal

Volumn 19, Issue 2, 2002, Pages 267-274

  Gaede, K I ^a   Wilke, G ^a   Brade, L ^a   Brade, H ^a   Schlaak, M ^a   Muller Quernheim J ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Bronchoalveolar lavage; Chlamydophila; Fluid; Sarcoidosis; Serum; Usual interstitial pneumoniae

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIAL SUPERINFECTION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INCIDENCE; INTERSTITIAL PNEUMONIA; LUNG INJURY; LUNG LAVAGE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SCREENING; SERUM; SPECIES DIFFERENCE;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BRONCHOALVEOLAR LAVAGE FLUID; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; LIPOPOLYSACCHARIDES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; SARCOIDOSIS, PULMONARY;

EID: 0036178712     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.02.00122002     Document Type: Article

References (37)

1. Sarcoidosis: Immunopathogenetic concepts and their clinical application
2. Differentiation of sarcoidosis from tuberculosis by use of electron capture gas-liquid chromatography
3. Epithelioid cell granulomatosis of the lung: New insights and concepts
4. Could Borrelia burgdorferi be a causal agent of sarcoidosis?
5. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis
6. Human herpesvirus 8 variants in sarcoid tissues
7. Serological response to Chlamydia pneumoniae in patients with sarcoidosis
8. The ornithosis complement fixation test in sarcoidosis
9. Failure to detect the presence of Chlamydia pneumoniae in sarcoid pathology specimens
10. Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification
11. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis
12. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis
13. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis
14. Bronchoalveolar macrophages from patients with idiopathic pulmonary fibrosis are unable to kill facultative intracellular bacteria
15. Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis
16. Consensus conference: Activity of sarcoidosis
17. Idiopathic pulmonary fibrosis
18. Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity
19. Structure, serological specificity, and synthesis of artificial glycoconjugates representing the genus-specific lipopolysaccharide epitope of Chlamydia spp
20. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen
21. Specificity of monoclonal antibodies against Echerichia coli K-12 lipopolysaccharide
22. Spontaneous and interleukin-2-modulated cytokine release by bronchoalveolar cells in pulmonary malignancy
23. Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide
24. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test
25. Chlamydia serology: Interlaboratory variation in microimmunofluorescence results
26. Infections with Chlamydia pneumoniae strain TWAR
27. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms
28. Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease
29. Systemic immune response of patients with active pulmonary sarcoidosis
30. Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes
31. IgA, IgG and IgM quantification in broncho-alveolar lavage fluids from allergic rhinitics, allergic asthmatics, and normal subjects by monoclonal antibody-based immunoenzymetric assays
32. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR
33. Asthma, atopy and Chlamydia pneumoniae antibodies in adults
34. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis
35. Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis
36. Two cases of lower respiratory tract infection due to Chlamydia pneumonia in Singapore
37. Interaction of Chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response